The effect of lower limb occlusion on recovery following sprint exercise in academy rugby players by Williams, Natalie et al.
  
 
© 2018 Elsevier. This is an author produced version of a paper 
accepted for publication in the Journal of Science and Medicine in 
Sport. Uploaded in accordance with the publisher’s self- archiving 
policy. 
Williams, N., Russell, M., Cook, C.J. & Kilduff, L.P. (2018). The effect 
of lower limn occlusion on recovery following sprint exercise in 
academy rugby players. Journal of Science and Medicine in Sport. 
(Published online ahead of print 3 March 2018). 
 
CC BY-NC-ND 3.0 
 1	
Title: The effect of lower limb occlusion on recovery following sprint exercise in academy 
rugby players 
 
Authors: Williams, N.a, b Russell, M.c, Cook, C.J.d,e, Kilduff, L.P.a, d  1	
 2	
 3	
a Applied Sports Technology Exercise and Medicine Research Centre (A-STEM), Swansea 4	
University, Swansea, United Kingdom  5	
b Sport Wales, Welsh Institute of Sport, Sophia Gardens, Cardiff, United Kingdom 6	
c School of Social and Health Sciences, Leeds Trinity University, Leeds, United Kingdom 7	
d Welsh Institute for Performance Solutions 8	
e University of Canberra Research Institute for Sport and Exercise, University of Canberra, 9	
Australia 10	
 11	
 12	
Corresponding Author:  Liam P.Kilduff 13	
   L.Kilduff@swansea.ac.uk 14	
 15	
Article type: Original investigation 16	
Abstract word count: 249 17	
Manuscript word count: 2936 18	
Figur 19	
 
 
 
 
 
 
 2	
Abstract 
 20	
Objectives: The effects of vascular occlusion on recovery of physiological and neuromuscular 21	
markers over 24h, and hormonal reactivity to subsequent exercise were investigated. 22	
Design: Counterbalanced, randomised, crossover  23	
Methods: Academy rugby players (n=24) completed six 50-m sprints (five-min inter-set 24	
recovery) before occlusion cuff application (thighs) and intermittent inflation to 171-266 25	
mmHg (Recovery) or 15 mmHg (Con) for 12-min (two sets, three-min repetitions, three-min 26	
non-occluded reperfusion). Countermovement jumps, blood (lactate, creatine kinase), saliva 27	
(testosterone, cortisol), and perceptual (soreness, recovery) responses were measured before 28	
(baseline) and after (post, +2h, +24h) sprinting.  Saliva was sampled after a 30-min resistance 29	
exercise session performed 24h after sprinting. 30	
Results: Although sprinting (total: 40.0 ± 2.8 s, p=0.238; average: 6.7 ± 0.5 s, p=0.674) 31	
influenced creatine kinase (p<0.001, +457.1 ± 327.3 µ·L-1, at 24h), lactate (p<0.001, 6.8 ± 2.3 32	
mmol·L-1, post), testosterone (p<0.001, -55.9 ± 63.2 pg·ml-1, at 2h) and cortisol (p<0.001, -33	
0.3 ± 0.3 µg·dl-1, at 2h) concentrations, countermovement jump power output (p<0.001, -34	
409.6 ± 310.1 W; -5.4 ± 3.4 cm, post), perceived recovery (p<0.001, -3.0 ± 2.3, post), and 35	
muscle soreness (p<0.001; 1.5 ± 1.1, at 24h), vascular occlusion had no effect (all p>0.05) on 36	
recovery. In response to subsequent exercise performed 24h after vascular occlusion, 37	
testosterone increased pre-to-post-exercise (Recovery: p=0.031, 21.6 ± 44.9 pg·ml-1; Con: 38	
p=0.178, 10.6 ± 36.6 pg·ml-1) however Δtestosterone was not significantly different 39	
(p=0.109) between conditions. 40	
Conclusions: Vascular occlusion had no effect on physiological or neuromuscular markers 2h 41	
or 24h after sprinting or in response to a physical stress test.    42	
 43	
Keywords: Occlusion, sprint, hormonal reactivity  44	
 3	
Introduction  45	
 46	
Physical and metabolic disturbances result from team sport match-play1.  Accordingly, 47	
various measures are applied to indicate the presence of exercise-induced muscle damage 48	
(EIMD) and the efficacy of recovery interventions2.  Elevated Creatine Kinase (CK) 49	
concentrations3, disruption in the hormonal milieu (i.e., testosterone; T, cortisol; C)4, and 50	
impairments in neuromuscular function (NMF) occur post-match5; with perturbations 51	
occurring for at least 48h3,5.  The use of hormonal responses, such as changes in T and C 52	
indicate anabolic and catabolic balance6 and thus readiness-to-train or competition-53	
preparedness, is an emerging concept in the fatigue-recovery paradigm7.  	54	 	55	
As short-term post-match fatigue impairs subsequent performance, recovery strategies (e.g. 56	
cold-water immersion and active recovery) are an integral component of weekly training 57	
practices that have been extensively investigated (for review see8).  More recently, vascular 58	
occlusion, the use of blood pressure cuffs applied on specific limbs to restrict blood-flow, has 59	
been suggested as a recovery strategy9,10.  While exact mechanisms are unclear, vascular 60	
occlusion is purported to elevate adenosine concentrations and activation of adenosine tri-61	
phosphate (ATP) sensitive potassium channels (KATP), increasing blood flow11 and benefiting 62	
oxygen and nutrient delivery via vasculature dilation; a response likely exaggerated during 63	
reperfusion, possibly improving substrate re-synthesis11. Alternatively, attenuated 64	
inflammatory responses10 and reduction of muscle oedema and intramuscular pressure 65	
decrease nocioreceptor stimulation, potentially reducing muscle soreness12. 66	 	67	
Unfortunately, the evidence for vascular occlusion as an effective post-exercise recovery 68	
modality is currently inconsistent. Two investigations identified improved recovery10,11 69	
whereas others13,14,15 disagree.  Methodological differences exist when implementing vascular 70	
occlusion, for example standardised cuff pressures have been implemented despite 71	
 4	
recommendations regarding individualised application relative to thigh girth and resting blood 72	
measurements16.  Similarly, inconsistent timings of recovery assessments (i.e., 1-72h) post-73	
occlusion exist between studies.  Previous research has also required players to remain rested 74	
for the duration of post-exercise recovery; however, this has limited application to applied 75	
practice where football or rugby players are frequently required to play multiple games within 76	
a week (i.e., <72h separating games), and train when complete physical recovery may not be 77	
achieved17.  Accordingly, identification of the physiological response to a subsequent physical 78	
stressor may denote if players are adequately recovered to return to training.  Notably, T is a 79	
stress biomarker; consequently, the monitoring of T in response to a physical stress test could 80	
provide information on readiness to train/compete18.   81	
 82	
The primary aim of the study was therefore to investigate the effects of post-exercise vascular 83	
occlusion (using individualised cuff pressures) on recovery (2h and 24h) of physiological and 84	
performance markers following maximal sprint exercise whilst also considering the hormonal 85	
reactivity to a subsequent exercise challenge performed at 24h.  It was hypothesised that 86	
vascular occlusion implemented post-exercise would facilitate the recovery of biochemical, 87	
neuromuscular and hormonal markers measured after 24h. 88	
 89	
Method  90	
 91	
Following institutional ethical approval and informed written consent, 24 male Academy 92	
rugby union players (age: 21.8 ± 3.0 y, mass: 96.9 ± 10.1 kg, stature: 1.85 ± 0.09 m) 93	
participated in the study during pre-season (1–2 sessions per day 4–5 days a week; strength, 94	
power, speed training). All participants were informed of the experimental procedures, the 95	
purpose of the study, and possible risks.  96	
 97	
Participants attended the testing venue four times.  Two main trials (Vascular occlusion: 98	
Recovery; Control: Con), seven days apart, were completed on an indoor 3G surface 99	
 5	
(temperature: 20°C; humidity: 41%) in a randomised, counter-balanced, crossover design.  100	
Measurement timings were consistent between trials to limit circadian variation, and 101	
participants refrained from alcohol and intense physical exercise in the 24h preceding trials.  102	
 103	
On arrival for main trials, participants rested for 10-min before recording blood pressure 104	
(Omron Healthcare, Europe; systolic >140 mmHg and diastolic >90 mmHg precluded further 105	
study involvement).  Thigh girth, physiological (capillary blood and saliva) and perceptual 106	
(soreness and recovery) assessments followed. After a 10-min standardised warm-up, 107	
participants performed two maximal countermovement jumps (CMJ) separated by 90 s 108	
(portable force platform: Type 92866AA, Kistler, Germany) to assess NMF5,19.  A further 10-109	
min warm-up followed (20 m dynamic exercises and accelerations, two-50 m sprints at 80% 110	
and 100% effort) with five-min of enforced rest before six-50 m (each separated by five-min 111	
rest) timed sprints (Brower Timing System, Salt Lake City, Utah, USA) were performed to 112	
induce muscle damage20,21 (Figure 1).  As per pre-exercise instructions, maximal effort was 113	
required across all six sprints, but no encouragement was provided during exercise. 114	
Participants and coaches were blinded from sprint timings and feedback was not provided 115	
until all trials were completed.	 	Average, and cumulative sprint times were recorded for the 116	
six sprints. 117	
 118	
Immediately post-exercise, baseline measures were repeated before occlusion cuffs were 119	
applied to the proximal point of the thighs while participants lay supine.  The cuff (11 cm; 120	
Sports Rehab Tourniquet, Sportsrehab) was manually inflated to 15 mmHg (Con), reflecting 121	
previous research9, or to 60% of individually calculated pressures (171-266 mmHg; 122	
Recovery), determined from thigh girth and blood pressure measurements16.  Cuffs were 123	
applied for a total of 12-min (two cycles of three-min occlusion, three-min reperfusion)9 as 124	
reports suggest that three-min cycles of occlusion fulfil the duration threshold and a total 125	
ischemic stimulus of at least four-min is required to elicit a protective effect in human 126	
myocardium, irrespective of the number of ischemic cycles22.  After 2h and 24h baseline 127	
 6	
measures were repeated; timings which are consistent with previous research20,21 and 128	
represent the duration between competition and return to training. 129	 	130	
To assess hormonal reactivity to a subsequent exercise stimulus performed after 24h, saliva 131	
was collected five-min before and immediately after a 30-min physical stress test (three sets 132	
of power cleans and back squats, four sets of bench press and bench pull at relative loads of 133	
60-85% 1RM; one and three-min rest between sets and exercises, respectively).  Participants 134	
were accustomed to the resistance exercise and testing procedures employed and these 135	
protocols were sufficient to elicit a stress response18. Session supervisors provided technical 136	
support only and were not aware of the condition that players were in. Feedback was not 137	
provided regarding within-session performance. 138	
 139	
***** INSERT FIGURE 1 NEAR HERE ***** 140	
 141	
Saliva collection required passive drooling (~2 ml) into a sterile vial (SalivaBio, Salimetrics 142	
LLC, USA) after refraining from brushing of teeth, drinking hot fluids, or eating hard foods 143	
2h beforehand.  All samples were stored (-15°C) immediately after collection and transferred 144	
to -80°C within 4h of collection.  Post thawing, centrifugation (Micro Centaur, MSE, London, 145	
United Kingdom; five-min at 3000 revolutions·min-1) preceded duplicate analysis of T and C 146	
concentrations due to known reliable reflections of gonadal function23 using indirect enzyme-147	
linked immunosorbent assay (ELISA) kits (Salimetrics Europe Ltd., Suffolk, U.K.).  The 148	
lowest detection limits for T and C were 6.1 pg·ml-1 and 0.012 µg·dl-1 respectively, and inter-149	
assay CV values were <10% in both cases.   150	
 151	
Participants provided a 20 µL fingertip capillary blood sample (analysed retrospectively for 152	
lactate concentrations; Biosen C-Line Clinic, EKF Diagnostic GmgH, Barleben, Germany).  153	
Additionally, 120 µL sample was collected, immediately centrifuged (3000 revolutions·min-1 154	
 7	
for 10-min; Labofuge 400R, Kendro Laboratories, Germany) for the extraction of plasma, and 155	
stored (−80°C) until later analysis. Plasma samples thawed before 6 µL was used for CK 156	
analysis (automated analyser; ABX Pentra 400, Horiba ABX, Montpellier, France).  Sample 157	
testing was carried out in duplicate, intra sample CV values were <2.0%.  158	
Perceived lower body muscle soreness was assessed using a 7-point Likert scale ranging from 159	
zero (complete absence of soreness) to six (severe pain limiting movement) which is reliable 160	
and valid24.  Perception of recovery status was assessed using a 11-point likert scale25 from 161	
zero (very poorly recovered/extremely tired) to 10 (very well recovered) which reflects 162	
changes in total sprint time relative to prior exercise21.  Participants were familiar with the 163	
scales and were asked to base scores on perceived soreness during normal movement and 164	
were alone when recording scores to reduce influences of peers. 165	
Assessment of CMJ was completed on a portable force platform (Kistler instrument Ltd., 166	
Farnborough, UK) sampling at 1000 Hz.  Peak power output (PPO) of the lower body was 167	
calculated as previously described19.  The vertical component of the ground reaction force and 168	
participants’ body weight were used to determine instantaneous velocity and displacement of 169	
the centre of gravity19. Instantaneous power output was determined using Equation 1 and the 170	
highest value produced was deemed PPO. Jump height (JH) was defined as the difference in 171	
vertical displacement of the center of gravity between take-off (toes leave the force plate) and 172	
maximum displacement19.  173	
 174	
Equation 1:  175	
Power (W) = Vertical ground reaction force (N) x vertical velocity of centre of gravity (m.s.-1) 176	
 177	
Statistical analysis 178	
 179	
All data is presented as mean ± standard deviation (SD).  Following confirmation of 180	
parametric assumptions, multivariate analysis of variance (MANOVA) with Bonferroni 181	
 8	
adjustment assessed between-trial differences for variables with multiple time points per trial 182	
(i.e. T, C, T:C ratio, perception muscle soreness and recovery, CK, blood lactate, PPO and 183	
JH). A one-way ANOVA was performed to assess between-trial differences in response to the 184	
physical stress test (T, C, T:C ratio and perception muscle soreness).  Paired samples t-tests 185	
were performed for between-trial comparisons of data expressed over a single time point 186	
within a trial (i.e. mean and total sprint times, T and C pre-and post-stress test).  Statistical 187	
analyses were carried out using SPSS (SPSS Chicago, IL) with significance being accepted at 188	
p≤0.05. 189	
 190	
Results 191	
 192	
There were no significant differences between conditions for total (Recovery: 39.86 ± 2.87 s; 193	
Con: 40.26 ± 2.77 s, p=0.238) or average (Recovery: 6.69 ± 0.47 s; Con: 6.71 ± 0.46 s, 194	
p=0.674) sprint times.  The Δlactate concentrations from pre-to-post sprinting showed no 195	
significant difference between conditions (Recovery: 6.88 ± 2.53 mmol·l-1, 85 ± 6%; Con: 196	
6.76 ± 2.04 mmol·l-1, 86 ± 5%, p=0.807, Figure 2). 197	
 198	
There was a significant time effect for CK (F(1,48)=72.928, p<0.001, Figure 2) with increases 199	
at 24h compared to pre-sprints in both Recovery (408.19 ± 291.45 µ·L-1, 55 ± 33%, p<0.001) 200	
and Con (506.02 ± 359.14 µ·L-1, 56 ± 34% p<0.001).  However, there was no significant 201	
interaction effects between condition and time (F(1, 48)=1.157, p=0.293). 202	
 203	
***** INSERT FIGURE 2 NEAR HERE ***** 204	
 205	
Muscle soreness (F(2, 95)=7.714, p<0.001) and perception of recovery (F(2, 88)=70.931, p<0.001) 206	
were affected by sprinting, with the greatest change in muscle soreness occurring 24h post 207	
exercise (Recovery: 1.5 ± 1.0; Con: 1.6 ± 1.1).  There was no significant interaction effects 208	
 9	
between time and condition for muscle soreness (F(2, 95)=0.009, p=0.993) or perception of 209	
recovery (F(2, 88)=0.158, p=0.924). 210	
 211	
Sprint exercise affected PPO (F(2, 96)=42.141, p<0.001) and JH (F(2, 82)=58.353, p<0.001) with 212	
PPO (Recovery: 417.74 ± 293.09 W, 8 ± 4%, p<0.001; Con: 401.46 ± 332.69 W, 7 ± 5%, p < 213	
0.001) and JH (Recovery: 5.49 ± 3.24 cm, 13 ± 7%, p<0.001; Con: 5.38 ± 3.66 cm, 13 ± 8%, 214	
p<0.001) decreasing post-sprints (Figure 3).  No further timing effects and no effect of 215	
Recovery on PPO (F(2, 96)=0.304, p=0.757) or JH (F(2, 82)=0.304, p=0.436) occurred. 216	
 217	
Sprinting increased T (F(2, 100)=20.127, p<0.001, Figure 2), T:C ratio (F(2, 95)=19.200, p<0.001) 218	
and decreased C (F(2, 89)=32.651, p<0.001, Figure 2).  However, condition did not affect the 219	
recovery of T (F(2, 100)=2.159, p=0.114), C (F(2, 89)=0.640, p=0.531) or T:C ratio (F(2, 95)=0.299, 220	
p=0.759).   221	
 222	
Testosterone significantly increased in response to the physical stress test in the Recovery 223	
(+21.58 ± 44.90 pg·ml-1, 7 ± 17%, p=0.031) but not the Con (+10.62 ± 36.57 pg·ml-1, 4 ± 224	
13%, p=0.178) with no differences in baseline values between conditions (p=0.232); 225	
however, ΔT was similar between conditions (p=0.109).  Cortisol declined over time 226	
(F(1,46)=7.806, p<0.001), pre-to post physical stress test (Recovery: -0.14 ± 0.23 µg·dl-1, 38 ± 227	
72%, p=0.007; Con: -0.17 ± 0.27 µg·dl-1, 50 ± 94%, p=0.006), with similar results for T:C 228	
ratio (F(1, 46)=29.836, p<0.001).  Recovery had no impact on hormonal response as no 229	
differences were observed between conditions (T; p=0.226, C; p=0.679, T:C; p=0.421). 230	
 231	
***** INSERT FIGURE 3 NEAR HERE ***** 232	
 233	
 234	
 235	
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Discussion 236	
 237	
This study aimed to investigate the effects of individualised vascular occlusion on recovery 238	
(2h and 24h) of physiological and neuromuscular indices following sprint exercise while also 239	
considering hormonal reactivity to subsequent training. Vascular occlusion did not influence 240	
the physiological or neuromuscular markers measured 2h or 24h after sprint exercise in 241	
Academy rugby players. Perception of muscle soreness was not different between conditions, 242	
sprinting, increased muscle soreness 24h post-exercise. As similar between-condition 243	
responses to a physical stress test occurred at 24h, vascular occlusion did not facilitate 244	
recovery following 2h or 24h of rest, nor change the hormonal response to a subsequent 245	
physical stress test.  Likewise, vascular occlusion did not detrimentally affect any measures 246	
assessed, recovery rate was not negatively influenced in comparison to Con, thus alleviating 247	
concerns about using this strategy, acutely, within season. 248	
 249	
Total (p=0.238) and average (p=0.674) sprint times were consistent between conditions with 250	
similar physiological responses being observed. Johnston et al.21 highlighted CK values 251	
increased by 570 µ·L-1 (current results +506.02 µ·L-1).  Compared to match responses, 252	
increases of 586.6 µ·L-1 (4; 24h post-soccer match) and 431 µ·L-1 (26; 16h post-rugby match) 253	
have been reported.  However, time and distance of maximal sprint completed in a match 254	
cannot be controlled and varies depending on position, therefore comparison against match 255	
outcome is difficult as many factors may influence performance on match day. Nevertheless, 256	
previous reports suggest that six 50m sprints reflect normal training sessions27.	257	
 258	
The current study individualised cuff pressure (171-226 mmHg) as a standard pressure 259	
applied to different individuals may non-uniformly influence the pressure exerted on the 260	
vasculature and thus impact the degree of blood flow restriction.  Loenneke et al.28 suggested 261	
that pressures aiming to restrict blood flow of the lower body should be determined by limb 262	
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circumference; findings supported by observations that thigh circumference is the biggest 263	
predictor of arterial occlusion in the lower body (β=0.570)16 with brachial systolic blood 264	
pressure being an additional significant predictor (β=0.231)16.  That said, in contradiction to 265	
the findings of Beaven et al.9 who identified improved peak power recovery 24h after 266	
occlusion, we observed no effects on recovery.  Although comparable vascular occlusion 267	
timings were used, cuff pressures differed between the studies (i.e., a standardised 220 mmHg 268	
versus individualised application).  Alternative methodological factors may be influencing the 269	
resulting outcome of vascular occlusion as a recovery modality; cuff pressure was determined 270	
from a regression equation16 based on non-elite participants, although this protocol considers 271	
thigh girth, tissue type (muscle or fat) may impact the level of blood flow restriction, a 272	
variable which will vary between elite-trained and untrained participants, training status may 273	
also impact effectiveness of vascular occlusion used for recovery.   274	
 275	
An alternative methodological discrepancy existing between previous research is the training 276	
status of participants.  Research completed by Beaven et al.9 investigated healthy, active non-277	
sport participating males and found vascular occlusion improved recovery.  However, 278	
Northey et al. 14 and the current study investigated the use of vascular occlusion in well-279	
trained individuals, identifying no effect on recovery. This potentially suggests that training 280	
status may mediate the efficacy of vascular occlusion as a recovery strategy. However, even 281	
with a group of active or well-trained participants, high inter-individual variability in EIMD 282	
marker responses has been found even when participants perform the same exercise29.  283	
Research suggests that the large inter-individual variability including non-modifiable factors 284	
(ethnicity, age, and gender) could be responsible for most of the equivocal findings and 285	
uncertainties regarding EIMD etiology29; another variable potentially explaining variation 286	
between the current study and previous work.  Therefore, it may be important to examine the 287	
use of vascular occlusion on an individual basis as it may offer a practical recovery option for 288	
some athletes/players and at some levels of performance. 289	
 12	
A novel aspect of this research was the response of a physical stress test as an indicator of 290	
recovery status and readiness-to-train following sprint exercise at 24h. Within the literature, 291	
previous recovery studies have assessed response to a recovery strategy when the athlete is 292	
rested, however players are frequently required to return to training 24h after a match. 293	
Therefore, hormonal response to a physical stress test may indicate if players are recovered 294	
and able to return to training.  In the current study, T increased pre-to post stress test in both 295	
conditions (Recovery: 21.58 ± 44.90 pg·ml-1, 7 ± 17%, p=0.031; Con: 10.62 ± 36.57 pg·ml-1, 296	
4 ± 13 %, p=0.178), but ΔT was not significantly different between conditions, suggesting 297	
Recovery had no impact on hormonal response.  Furthermore, C showed a significant decline 298	
from pre-to post-stress test in both the Recovery (0.14 ± 0.23 µg·dl-1, 38 ± 72%, p=0.007) and 299	
Con (0.17 ± 0.27 µg·dl-1, 50 ± 94%, p=0.006).  Therefore, consistent with rested results, there 300	
was no difference between conditions regarding rate of recovery following a physical stress 301	
test. 302	
 303	
Limitations of the research should be acknowledged; the placebo effect is not accounted for, 304	
which may be important to consider. Within Con, cuffs were still applied and therefore is 305	
difficult to blind participants from the conditions due to the obvious difference in cuff 306	
pressure.  Therefore, a further condition would be optimal to identify the impact of vascular 307	
occlusion, determining whether there is a placebo or physiological effect on performance 308	
when compared against a control in which cuffs are absent as completed by Marocolo et al. 30.  309	
Similarly, it is difficult to blind testers to conditions due to variation in cuff pressure, 310	
however, all testers and coaches were informed that no verbal encouragement was to be given 311	
during exercise (sprints, jumps, stress test). 	312	
 313	
Conclusions 314	
 315	
The data presented in this investigation highlight application of two cycles of vascular 316	
occlusion administered intermittently after sprinting did not influence, either positively or 317	
 13	
negatively, physiological or neuromuscular markers of recovery assessed after 2h or 24h of 318	
rest or after a subsequent physical stress test.   319	
 320	
Practical Implications 321	
• Individualised vascular occlusion applied post-exercise didn’t influence recovery or 322	
readiness-to-train after 24h 323	
• An absence of negative effects for physiological and performance markers alleviates 324	
concerns about the use of vascular occlusion within season  325	
• Methodological variations (such as exercise protocol, cuff pressure, duration of 326	
occlusion and training status) may be modulating the efficacy of vascular occlusion 327	
as a recovery strategy  328	
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Figure 1: Timeline of data collection. Con; control trial, Recovery; occlusion trial, RE; 428	
resistance exercise. Measurements: salivary testosterone, salivary cortisol (•), blood sampling 429	
for blood lactate and Creatine Kinase ( ), perception muscle soreness questionnaires (♦), 430	
countermovement jump (◊) 431	
 432	
 433	
Figure 2: Physiological responses (a) Testosterone (b) cortisol (c) Creatine Kinase (d) Blood 434	
lactate collected pre, post, 2 h and 24 h post sprint protocol (* p<0.05) 435	
 436	
Figure 3: (a) Peak power output and (b) jump height, determined from countermovement 437	
jump collected pre, post, 2 h and 24 h post sprint 438	
 439	
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